Austin, March 20, 2026 (GLOBE NEWSWIRE)-- According to SNS Insider, The Insulin Delivery Devices Market size was valued at USD 19.13 billion in 2025 and is expected to reach USD 41.00 billion by 2035, ...
Eli Lilly is scaling back its legacy insulin footprint in Europe, with plans to discontinue a swath of products for “commercial reasons.” The company is removing several of its insulin presentations, ...
The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...
13d
Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs
A bipartisan group of senators is aiming to relieve high insulin costs for more Americans. A new bill introduced last week ...
A bipartisan group of senators is resurfacing legislation to cap many American patients’ insulin costs at $35 a month — the INSULIN Act of 2026 — reviving a push that previously stalled. The bill, ...
Advocates expect the young adult population to especially benefit from the bill, since many struggle to get high-quality ...
If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...
March 24 (Reuters) - CVS Health (CVS.N), opens new tab said on Tuesday it has reached a proposed settlement agreement with the Federal Trade Commission on insulin pricing. Pharmacy benefit managers, ...
March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's (NOVOb.CO), opens new tab insulin injection, Awiqli, to control blood sugar levels in adults living with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results